Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Alpha Cognition Inc. (ACOG) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.Alpha Cognition Inc. is a member of the Medical sector. This group includes 950 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Alpha Cognition Inc. is currently sporting a Zacks Rank of #2 (Buy).Over the past three months, the Zacks Consensus Estimate for ACOG's full-year earnings has moved 30% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.Our latest available data shows that ACOG has returned about 8.2% since the start of the calendar year. At the same time, Medical stocks have gained an average of 6.5%. This means that Alpha Cognition Inc. is performing better than its sector in terms of year-to-date returns.One other Medical stock that has outperformed the sector so far this year is Actinium Pharmaceuticals (ATNM). The stock is up 15.1% year-to-date.The consensus estimate for Actinium Pharmaceuticals' current year EPS has increased 11.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).Looking more specifically, Alpha Cognition Inc. belongs to the Medical - Biomedical and Genetics industry, a group that includes 467 individual stocks and currently sits at #91 in the Zacks Industry Rank. On average, stocks in this group have gained 19.9% this year, meaning that ACOG is slightly underperforming its industry in terms of year-to-date returns. Actinium Pharmaceuticals, however, belongs to the Medical - Drugs industry. Currently, this 147-stock industry is ranked #79. The industry has moved +7.9% so far this year.Investors interested in the Medical sector may want to keep a close eye on Alpha Cognition Inc. and Actinium Pharmaceuticals as they attempt to continue their solid performance.Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Alpha Cognition Inc. (ACOG): Free Stock Analysis Report Actinium Pharmaceuticals, Inc. (ATNM): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks